26 October 2018
The combination of intelligent technologies and biotechnology are transforming medicine. Smart medical devices are increasingly used, be it 3D-printed biomaterials for cartilage or tissue replacement or intelligent implants with integrated biosensors. At the RegMed Forum, on 18 October in Berlin, international experts from industry and academia discussed the use, the shifting conditions for approval and the future applications of these products.
"Biologization and digitization enable innovative approaches, which will fundamentally change medical care in a range of indications”, explained Professor Georg N. Duda, Director of the Julius Wolff Institute for Biomechanics and Musculoskeletal Regeneration and Deputy Director of the BCRT at this year's RegMed Forum. "In addition to the pursuit of innovation opportunities, we must increasingly ask ourselves how the critical clinical benefit – that is the benefit for the patient – of such innovations can be demonstrated."
Attendees of the conference, organized for the fifth time by the Berlin-Brandenburg Center for Regenerative Therapies (BCRT) and Berlin Partner for Business and Technology GmbH, discussed the latest trends in intelligent medicine. Renowned speakers from Europe and the United States gave scientific and clinical input that ranged from biologically active implants to the adaptive control of insulin pumps. A spirit panel talked the audience through the challenges of the new medical device directive for both manufacturers and developers.